| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 399 | 255 | 138 | 0 | 76 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 399 | 255 | 138 | 0 | 76 | 0 | 0 | 0 | 0 | 5 |
| Total Expenses - EUR | 854 | 528 | 2.339 | 699 | 631 | 602 | 290 | 218 | 361 | 931 |
| Gross Profit/Loss - EUR | -455 | -273 | -2.201 | -699 | -555 | -602 | -290 | -218 | -361 | -925 |
| Net Profit/Loss - EUR | -467 | -280 | -2.205 | -699 | -558 | -602 | -290 | -218 | -361 | -925 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Natural Biosolaris Grup Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 11.199 | 10.784 | 8.368 | 7.403 | 9.113 | 8.337 | 7.902 | 7.709 | 9.548 | 8.383 |
| Inventories | 2.029 | 2.025 | 326 | 310 | 600 | 589 | 576 | 577 | 585 | 9 |
| Receivables | 7.145 | 7.112 | 7.048 | 7.002 | 6.936 | 6.861 | 6.716 | 6.742 | 6.715 | 6.687 |
| Cash | 2.025 | 1.646 | 994 | 91 | 1.577 | 888 | 611 | 391 | 2.248 | 1.687 |
| Shareholders Funds | -856 | -1.128 | -3.314 | -3.952 | -4.433 | -4.952 | -5.132 | -5.366 | -5.711 | -6.604 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 12.056 | 11.912 | 11.681 | 11.356 | 13.546 | 13.289 | 13.035 | 13.076 | 15.259 | 14.987 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "113 - 113" | |||||||||
| CAEN Financial Year |
113
|
|||||||||
Comments - Natural Biosolaris Grup Srl